TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

David W. Vredevoogd(The Netherlands Cancer Institute), Daniel S. Peeper(The Netherlands Cancer Institute)
Journal for ImmunoTherapy of Cancer
November 1, 2024
Cited by 3


Related Papers